Liansheng Chemical: On March 17, margin buying of 6.0586 million yuan, margin financing and securities lending balance of 49.3422 million yuan

NightAirdropper · 2026-03-19T06:54:33+00:00

Lianteng Chemical (301212) had margin buying of 6.0586 million yuan on March 17, margin repayment of 8.3279 million yuan, net selling of 2.2693 million yuan, and margin balance of 49.0278 million yuan. There were no short selling activities, with total margin balance of 49.3422 million yuan, down 4.43% from the previous day. The margin financing and short selling situation reflects changes in market sentiment.

NightAirdropper

2026-03-19 06:54:33

Abstract generation in progress

Securities Star News, March 17: Lian Sheng Chemical (301212) had a margin buy-in of 6.0586 million yuan, margin repayment of 8.3279 million yuan, resulting in a net margin sell of 2.2693 million yuan, with a margin balance of 49.0278 million yuan.

There were no securities lending transactions on that day.

The total margin financing and securities lending balance is 49.3422 million yuan, down 4.43% from yesterday.

Quick Facts

Margin Financing and Securities Lending: An increase in margin financing balance indicates strengthening bullish market sentiment, while a decrease suggests a wait-and-see or bearish sentiment. Conversely, an increase in securities lending balance indicates growing bearish market sentiment, and a decrease indicates a shift toward a wait-and-see or bullish sentiment. It’s important to note that due to the financial leverage effect of margin financing and securities lending, they are a double-edged sword for investors—like a magnifying glass. Profits can multiply in gains, but losses can also be amplified significantly.

The above content is compiled from publicly available information by Securities Star, generated by AI algorithm (Wangxin Calculation Backup 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes